Breaking News Instant updates and real-time market news.

B

Barnes Group

$39.92 /

-0.75 (-1.84%)

08:38
11/29/22
11/29
08:38
11/29/22
08:38

Barnes Group price target raised to $48 from $42 at Oppenheimer

Oppenheimer analyst Christopher Glynn raised the firm's price target on Barnes Group to $48 from $42 following meetings with the company's management. The analyst keeps an Outperform rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Rockwell Medical price target lowered to $7 from $8 at H.C. Wainwright » 06:11
02/08/23
02/08
06:11
02/08/23
06:11
RMTI

Rockwell Medical

$1.90 /

-0.07 (-3.55%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RMTI Rockwell Medical
$1.90 /

-0.07 (-3.55%)

RMTI Rockwell Medical
$1.90 /

-0.07 (-3.55%)

08/30/22 H.C. Wainwright
Rockwell Medical price target raised to $8 from $3 at H.C. Wainwright
RMTI Rockwell Medical
$1.90 /

-0.07 (-3.55%)

Initiation
Nouveau Monde initiated with a Buy at H.C. Wainwright » 06:11
02/08/23
02/08
06:11
02/08/23
06:11
NMG

Nouveau Monde

$5.44 /

-0.11 (-1.98%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NMG Nouveau Monde
$5.44 /

-0.11 (-1.98%)

NMG Nouveau Monde
$5.44 /

-0.11 (-1.98%)

10/27/22 B. Riley
Nouveau Monde assumed with a Buy at B. Riley
NMG Nouveau Monde
$5.44 /

-0.11 (-1.98%)

Recommendations
Vertex Pharmaceuticals price target raised to $325 from $300 at H.C. Wainwright » 06:09
02/08/23
02/08
06:09
02/08/23
06:09
VRTX

Vertex Pharmaceuticals

$308.78 /

+3.835 (+1.26%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$308.78 /

+3.835 (+1.26%)

VRTX Vertex Pharmaceuticals
$308.78 /

+3.835 (+1.26%)

05:40 Today Barclays
Vertex Pharmaceuticals price target raised to $342 from $313 at Barclays
01/19/23 Piper Sandler
Vertex Pharmaceuticals price target raised to $296 from $293 at Piper Sandler
01/18/23 Canaccord
Vertex Pharmaceuticals initiated with a Hold at Canaccord
01/17/23 SVB Securities
SVB Securities upgrades Vertex to Outperform, raises price target to $374
VRTX Vertex Pharmaceuticals
$308.78 /

+3.835 (+1.26%)

VRTX Vertex Pharmaceuticals
$308.78 /

+3.835 (+1.26%)

VRTX Vertex Pharmaceuticals
$308.78 /

+3.835 (+1.26%)

VRTX Vertex Pharmaceuticals
$308.78 /

+3.835 (+1.26%)

Hot Stocks
Coherent transfer listing to NYSE from Nasdaq » 06:09
02/08/23
02/08
06:09
02/08/23
06:09
COHR

Coherent

$43.90 /

+1.2 (+2.81%)

Coherent announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COHR Coherent
$43.90 /

+1.2 (+2.81%)

COHR Coherent
$43.90 /

+1.2 (+2.81%)

01/23/23 Barclays
Coherent price target raised to $36 from $30 at Barclays
01/17/23 Rosenblatt
Coherent initiated with a Buy at Rosenblatt
01/11/23 Craig-Hallum
Lumentum price target lowered to $75 from $80 at Craig-Hallum
12/20/22 JPMorgan
Coherent price target lowered to $52 from $74 at JPMorgan
COHR Coherent
$43.90 /

+1.2 (+2.81%)

COHR Coherent
$43.90 /

+1.2 (+2.81%)

COHR Coherent
$43.90 /

+1.2 (+2.81%)

Upgrade
TripAdvisor upgraded to Buy from Underperform at BofA » 06:09
02/08/23
02/08
06:09
02/08/23
06:09
TRIP

TripAdvisor

$24.16 /

+0.46 (+1.94%)

BofA analyst Nat…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$24.16 /

+0.46 (+1.94%)

TRIP TripAdvisor
$24.16 /

+0.46 (+1.94%)

12/07/22 Wolfe Research
TripAdvisor downgraded to Underperform from Peer Perform at Wolfe Research
11/25/22 DA Davidson
TripAdvisor price target lowered to $30 from $33 at DA Davidson
11/09/22 Wells Fargo
TripAdvisor price target lowered to $22 from $30 at Wells Fargo
11/09/22 Mizuho
TripAdvisor price target lowered to $22 from $26 at Mizuho
TRIP TripAdvisor
$24.16 /

+0.46 (+1.94%)

TRIP TripAdvisor
$24.16 /

+0.46 (+1.94%)

TRIP TripAdvisor
$24.16 /

+0.46 (+1.94%)

Hot Stocks
Perion Network announces six-month CEO transition period » 06:09
02/08/23
02/08
06:09
02/08/23
06:09
PERI

Perion Network

$33.53 /

-0.21 (-0.62%)

Perion Network announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PERI Perion Network
$33.53 /

-0.21 (-0.62%)

01/30/23 Needham
Perion Network price target raised to $37 from $32 at Needham
01/20/23 Lake Street
Lake Street 'comfortable' with revenue growth forecast for Perion Network
02/10/22 Oppenheimer
Perion Network price target lowered to $30 from $35 at Oppenheimer
PERI Perion Network
$33.53 /

-0.21 (-0.62%)

PERI Perion Network
$33.53 /

-0.21 (-0.62%)

PERI Perion Network
$33.53 /

-0.21 (-0.62%)

Recommendations
Target price target raised to $220 from $200 at Piper Sandler » 06:08
02/08/23
02/08
06:08
02/08/23
06:08
TGT

Target

$174.77 /

+0.885 (+0.51%)

, BBBY

Bed Bath & Beyond

$3.01 /

-2.84 (-48.55%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGT Target
$174.77 /

+0.885 (+0.51%)

BBBY Bed Bath & Beyond
$3.01 /

-2.84 (-48.55%)

TGT Target
$174.77 /

+0.885 (+0.51%)

02/07/23 Barclays
Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
02/07/23 Barclays
Target initiated with an Equal Weight at Barclays
01/23/23 Oppenheimer
Target initiated with an Outperform at Oppenheimer
01/04/23 Wells Fargo
Wells Fargo downgrades Target to Equal Weight, lowers price target to $142
BBBY Bed Bath & Beyond
$3.01 /

-2.84 (-48.55%)

02/07/23 Odeon Capital
Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital
02/07/23 Wedbush
Wedbush cuts Bed Bath & Beyond target to 0c amid last effort to avoid bankruptcy
01/11/23 Wedbush
Bed Bath & Beyond price target lowered to $1 from $5 at Wedbush
01/11/23 Baird
Bed Bath & Beyond price target lowered to $1.00 from $2.00 at Baird
TGT Target
$174.77 /

+0.885 (+0.51%)

BBBY Bed Bath & Beyond
$3.01 /

-2.84 (-48.55%)

TGT Target
$174.77 /

+0.885 (+0.51%)

BBBY Bed Bath & Beyond
$3.01 /

-2.84 (-48.55%)

TGT Target
$174.77 /

+0.885 (+0.51%)

BBBY Bed Bath & Beyond
$3.01 /

-2.84 (-48.55%)

TGT Target
$174.77 /

+0.885 (+0.51%)

BBBY Bed Bath & Beyond
$3.01 /

-2.84 (-48.55%)

Earnings
Edgewell Personal Care reports Q1 adjusted EPS 31c, consensus 21c » 06:08
02/08/23
02/08
06:08
02/08/23
06:08
EPC

Edgewell Personal Care

$42.14 /

-0.85 (-1.98%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPC Edgewell Personal Care
$42.14 /

-0.85 (-1.98%)

EPC Edgewell Personal Care
$42.14 /

-0.85 (-1.98%)

11/16/22 Canaccord
Canaccord starts Edgewell Personal Care at Buy amid men's 'beauty boom'
11/16/22 Canaccord
Edgewell Personal Care initiated with a Buy at Canaccord
11/14/22 Barclays
Edgewell Personal Care price target raised to $35 from $31 at Barclays
10/25/22 Goldman Sachs
Edgewell downgraded to Neutral from Conviction Buy at Goldman Sachs
EPC Edgewell Personal Care
$42.14 /

-0.85 (-1.98%)

Earnings
Ingredion sees FY23 adjusted EPS $7.70-$8.40, consensus $8.22 » 06:08
02/08/23
02/08
06:08
02/08/23
06:08
INGR

Ingredion

$100.65 /

-0.835 (-0.82%)

The company expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INGR Ingredion
$100.65 /

-0.835 (-0.82%)

INGR Ingredion
$100.65 /

-0.835 (-0.82%)

01/23/23 Barclays
Ingredion downgraded to Equal Weight from Overweight at Barclays
01/17/23 Stephens
Ingredion upgraded to Overweight from Equal Weight at Stephens
11/07/22 Credit Suisse
Ingredion price target raised to $100 from $94 at Credit Suisse
09/30/22 UBS
Ingredion initiated with a Neutral at UBS
INGR Ingredion
$100.65 /

-0.835 (-0.82%)

INGR Ingredion
$100.65 /

-0.835 (-0.82%)

Upgrade
Royal Caribbean upgraded to Neutral from Underperform at BofA » 06:07
02/08/23
02/08
06:07
02/08/23
06:07
RCL

Royal Caribbean

$74.05 /

+4.96 (+7.18%)

BofA analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$74.05 /

+4.96 (+7.18%)

RCL Royal Caribbean
$74.05 /

+4.96 (+7.18%)

05:34 Today Barclays
Royal Caribbean price target raised to $88 from $74 at Barclays
04:44 Today Deutsche Bank
Royal Caribbean price target raised to $65 from $62 at Deutsche Bank
01/31/23 Citi
Royal Caribbean offers most value in cruise sector, says Citi
01/20/23 Deutsche Bank
Royal Caribbean price target raised to $62 from $48 at Deutsche Bank
RCL Royal Caribbean
$74.05 /

+4.96 (+7.18%)

RCL Royal Caribbean
$74.05 /

+4.96 (+7.18%)

RCL Royal Caribbean
$74.05 /

+4.96 (+7.18%)

RCL Royal Caribbean
$74.05 /

+4.96 (+7.18%)

Earnings
Ingredion reports Q4 adjusted EPS $1.65, consensus $1.45 » 06:06
02/08/23
02/08
06:06
02/08/23
06:06
INGR

Ingredion

$100.65 /

-0.835 (-0.82%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INGR Ingredion
$100.65 /

-0.835 (-0.82%)

INGR Ingredion
$100.65 /

-0.835 (-0.82%)

01/23/23 Barclays
Ingredion downgraded to Equal Weight from Overweight at Barclays
01/17/23 Stephens
Ingredion upgraded to Overweight from Equal Weight at Stephens
11/07/22 Credit Suisse
Ingredion price target raised to $100 from $94 at Credit Suisse
09/30/22 UBS
Ingredion initiated with a Neutral at UBS
INGR Ingredion
$100.65 /

-0.835 (-0.82%)

INGR Ingredion
$100.65 /

-0.835 (-0.82%)

Hot Stocks
Maxar Technologies awarded $192M contract by the NGA » 06:06
02/08/23
02/08
06:06
02/08/23
06:06
MAXR

Maxar Technologies

$51.67 /

+0.03 (+0.06%)

Maxar Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAXR Maxar Technologies
$51.67 /

+0.03 (+0.06%)

MAXR Maxar Technologies
$51.67 /

+0.03 (+0.06%)

12/27/22 Morgan Stanley
Morgan Stanley says space-related M&A highlight attractiveness of end market
12/19/22 Northland
Maxar deal sheds light on growing value of Planet Labs data, says Northland
12/19/22 TD Securities
Maxar Technologies downgraded to Tender from Buy at TD Securities
12/19/22 RBC Capital
Maxar Technologies downgraded to Sector Perform from Outperform at RBC Capital
MAXR Maxar Technologies
$51.67 /

+0.03 (+0.06%)

MAXR Maxar Technologies
$51.67 /

+0.03 (+0.06%)

MAXR Maxar Technologies
$51.67 /

+0.03 (+0.06%)

Earnings
CVS Health sees FY24 adjusted EPS $9.00, FY25 adjusted EPS $10.00 » 06:05
02/08/23
02/08
06:05
02/08/23
06:05
CVS

CVS Health

$86.02 /

+0.77 (+0.90%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

02/07/23 Stifel
Oak Street Health price target raised to $39 from $35 at Stifel
02/07/23 Piper Sandler
Oak Street 'particularly attractive' in current environment, says Piper Sandler
01/31/23 JPMorgan
Medicare Advantage final rule more favorable than feared, says JPMorgan
01/27/23 Lake Street
Medavail price target lowered to $1 from $4 at Lake Street
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

Earnings
Bunge sees FY23 adjusted EPS 'at least' $11.00, consensus $12.00 » 06:05
02/08/23
02/08
06:05
02/08/23
06:05
BG

Bunge

$98.92 /

-0.64 (-0.64%)

In Agribusiness,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BG Bunge
$98.92 /

-0.64 (-0.64%)

BG Bunge
$98.92 /

-0.64 (-0.64%)

12/14/22 UBS
UBS starts Bunge at Buy on near-term earnings power
12/13/22 UBS
Bunge initiated with a Buy at UBS
10/24/22 BofA
Green Plains price target lowered to $35 from $43 at BofA
10/24/22 BofA
Bunge price target lowered to $130 from $138 at BofA
BG Bunge
$98.92 /

-0.64 (-0.64%)

BG Bunge
$98.92 /

-0.64 (-0.64%)

BG Bunge
$98.92 /

-0.64 (-0.64%)

Recommendations
Tenable Holdings price target raised to $55 from $50 at Piper Sandler » 06:04
02/08/23
02/08
06:04
02/08/23
06:04
TENB

Tenable Holdings

$43.41 /

+0.965 (+2.27%)

Piper Sandler analyst Rob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TENB Tenable Holdings
$43.41 /

+0.965 (+2.27%)

TENB Tenable Holdings
$43.41 /

+0.965 (+2.27%)

05:36 Today Barclays
Tenable Holdings price target raised to $50 from $42 at Barclays
01/24/23 JPMorgan
Tenable Holdings initiated with a Neutral at JPMorgan
01/12/23 Morgan Stanley
Tenable Holdings downgraded at Morgan Stanley amid near-term security caution
01/12/23 Morgan Stanley
Tenable Holdings downgraded to Equal Weight from Overweight at Morgan Stanley
TENB Tenable Holdings
$43.41 /

+0.965 (+2.27%)

TENB Tenable Holdings
$43.41 /

+0.965 (+2.27%)

Periodicals
Google plans to roll out AI-powered search features, WSJ reports » 06:04
02/08/23
02/08
06:04
02/08/23
06:04
GOOG

Alphabet

$108.01 /

+4.53 (+4.38%)

, GOOGL

Alphabet

$107.69 /

+4.74 (+4.60%)

, MSFT

Microsoft

$267.58 /

+10.605 (+4.13%)

Google (GOOG;GOOGL) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$108.01 /

+4.53 (+4.38%)

GOOGL Alphabet
$107.69 /

+4.74 (+4.60%)

MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

GOOG Alphabet
$108.01 /

+4.53 (+4.38%)

02/07/23 Wedbush
Microsoft set to unveil ChatGPT partnership as AI arms race begins, says Wedbush
02/03/23 JPMorgan
Alphabet price target raised to $118 from $115 at JPMorgan
02/03/23 Credit Suisse
Alphabet price target lowered to $136 from $145 at Credit Suisse
02/03/23 Morgan Stanley
Alphabet price target raised to $135 from $125 at Morgan Stanley
GOOGL Alphabet
$107.69 /

+4.74 (+4.60%)

02/07/23 Wedbush
Microsoft set to unveil ChatGPT partnership as AI arms race begins, says Wedbush
02/03/23 Truist
Alphabet price target lowered to $120 from $130 at Truist
02/03/23 DA Davidson
Amazon.com price target raised to $134 from $114 at DA Davidson
02/03/23 Roth MKM
Alphabet price target raised to $126 from $120 at Roth MKM
MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

06:03 Today Piper Sandler
Microsoft price target raised to $290 from $247 at Piper Sandler
05:21 Today Jefferies
Microsoft price target raised to $310 from $275 at Jefferies
02/07/23 Stifel
Stifel says average public ad tech multiple values Criteo near $45 per share
02/07/23 Wedbush
Microsoft set to unveil ChatGPT partnership as AI arms race begins, says Wedbush
GOOG Alphabet
$108.01 /

+4.53 (+4.38%)

GOOGL Alphabet
$107.69 /

+4.74 (+4.60%)

MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

GOOG Alphabet
$108.01 /

+4.53 (+4.38%)

GOOGL Alphabet
$107.69 /

+4.74 (+4.60%)

MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

GOOG Alphabet
$108.01 /

+4.53 (+4.38%)

GOOGL Alphabet
$107.69 /

+4.74 (+4.60%)

MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

GOOG Alphabet
$108.01 /

+4.53 (+4.38%)

GOOGL Alphabet
$107.69 /

+4.74 (+4.60%)

MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

Earnings
CVS Health backs FY23 adjusted EPS view $8.70-$8.90, consensus $8.86  06:04
02/08/23
02/08
06:04
02/08/23
06:04
CVS

CVS Health

$86.02 /

+0.77 (+0.90%)

 
ShowHide Related Items >><<
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

02/07/23 Stifel
Oak Street Health price target raised to $39 from $35 at Stifel
02/07/23 Piper Sandler
Oak Street 'particularly attractive' in current environment, says Piper Sandler
01/31/23 JPMorgan
Medicare Advantage final rule more favorable than feared, says JPMorgan
01/27/23 Lake Street
Medavail price target lowered to $1 from $4 at Lake Street
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

Recommendations
Fortinet price target raised to $64 from $57 at Piper Sandler » 06:04
02/08/23
02/08
06:04
02/08/23
06:04
FTNT

Fortinet

$53.71 /

+1.745 (+3.36%)

Piper Sandler analyst Rob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTNT Fortinet
$53.71 /

+1.745 (+3.36%)

FTNT Fortinet
$53.71 /

+1.745 (+3.36%)

02/06/23 Loop Capital
Loop Capital starts Fortinet at Buy, sees security spend stable beyond near term
02/06/23 Loop Capital
Fortinet initiated with a Buy at Loop Capital
02/02/23 BMO Capital
Fortinet downgraded to Market Perform from Outperform at BMO Capital
01/31/23 MKM Partners
Fortinet price target lowered to $65 from $70 at MKM Partners
FTNT Fortinet
$53.71 /

+1.745 (+3.36%)

FTNT Fortinet
$53.71 /

+1.745 (+3.36%)

FTNT Fortinet
$53.71 /

+1.745 (+3.36%)

FTNT Fortinet
$53.71 /

+1.745 (+3.36%)

Recommendations
Microsoft price target raised to $290 from $247 at Piper Sandler » 06:03
02/08/23
02/08
06:03
02/08/23
06:03
MSFT

Microsoft

$267.58 /

+10.605 (+4.13%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

05:21 Today Jefferies
Microsoft price target raised to $310 from $275 at Jefferies
02/07/23 Stifel
Stifel says average public ad tech multiple values Criteo near $45 per share
02/07/23 Wedbush
Microsoft set to unveil ChatGPT partnership as AI arms race begins, says Wedbush
01/27/23 BMO Capital
SAP price target raised to $125 from $110 at BMO Capital
MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

MSFT Microsoft
$267.58 /

+10.605 (+4.13%)

Hot Stocks
CVS Health to acquire Oak Street Health for $39 per share » 06:03
02/08/23
02/08
06:03
02/08/23
06:03
CVS

CVS Health

$86.02 /

+0.77 (+0.90%)

, OSH

Oak Street Health

$33.67 /

+7.64 (+29.35%)

CVS Health (CVS) and Oak…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

02/07/23 Stifel
Oak Street Health price target raised to $39 from $35 at Stifel
02/07/23 Piper Sandler
Oak Street 'particularly attractive' in current environment, says Piper Sandler
01/31/23 JPMorgan
Medicare Advantage final rule more favorable than feared, says JPMorgan
01/27/23 Lake Street
Medavail price target lowered to $1 from $4 at Lake Street
OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

02/07/23 Stifel
Oak Street Health price target raised to $39 from $35 at Stifel
02/07/23 Piper Sandler
Oak Street 'particularly attractive' in current environment, says Piper Sandler
01/12/23 Piper Sandler
Oak Street could be worth over $49 per share in buyout, says Piper Sandler
01/12/23 Raymond James
Raymond James upgrades Oak Street on potential takeout by CVS
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

  • 17
    Aug
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

Hot Stocks
UniFirst to acquire Clean Uniform for $300M » 06:02
02/08/23
02/08
06:02
02/08/23
06:02
UNF

UniFirst

$202.28 /

+0.325 (+0.16%)

UniFirst announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNF UniFirst
$202.28 /

+0.325 (+0.16%)

UNF UniFirst
$202.28 /

+0.325 (+0.16%)

01/05/23 Baird
UniFirst price target raised to $225 from $199 at Baird
05/18/22 Baird
UniFirst price target lowered to $195 from $213 at Baird
04/01/22 JPMorgan
UniFirst downgraded to sell on missed earnings pattern at JPMorgan
04/01/22 JPMorgan
UniFirst downgraded to Underweight from Neutral at JPMorgan
UNF UniFirst
$202.28 /

+0.325 (+0.16%)

UNF UniFirst
$202.28 /

+0.325 (+0.16%)

Earnings
Radware reports Q4 non-GAAP EPS 17c, consensus 17c » 06:01
02/08/23
02/08
06:01
02/08/23
06:01
RDWR

Radware

$22.20 /

+0.39 (+1.79%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDWR Radware
$22.20 /

+0.39 (+1.79%)

RDWR Radware
$22.20 /

+0.39 (+1.79%)

11/03/22 Jefferies
Radware downgraded to Hold at Jefferies amid sales execution issues
11/03/22 Jefferies
Radware downgraded to Hold from Buy at Jefferies
08/08/22 Needham
Radware downgraded to Hold at Needham without 'enough conviction'
08/08/22 Needham
Radware downgraded to Hold from Buy at Needham
RDWR Radware
$22.20 /

+0.39 (+1.79%)

Recommendations
OneMain Holdings price target raised to $55 from $49 at JMP Securities » 06:01
02/08/23
02/08
06:01
02/08/23
06:01
OMF

OneMain Holdings

$46.80 /

+4.44 (+10.48%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMF OneMain Holdings
$46.80 /

+4.44 (+10.48%)

OMF OneMain Holdings
$46.80 /

+4.44 (+10.48%)

05:33 Today Barclays
OneMain Holdings price target raised to $46 from $39 at Barclays
01/27/23 BMO Capital
World Acceptance price target lowered to $32 from $46 at BMO Capital
01/13/23 JMP Securities
OneMain Holdings price target lowered to $49 from $54 at JMP Securities
01/06/23 Barclays
OneMain Holdings downgraded to Equal Weight from Overweight at Barclays
OMF OneMain Holdings
$46.80 /

+4.44 (+10.48%)

OMF OneMain Holdings
$46.80 /

+4.44 (+10.48%)

Earnings
Bunge reports Q4 adjusted EPS $3.24, consensus $3.22 » 06:01
02/08/23
02/08
06:01
02/08/23
06:01
BG

Bunge

$98.92 /

-0.64 (-0.64%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BG Bunge
$98.92 /

-0.64 (-0.64%)

BG Bunge
$98.92 /

-0.64 (-0.64%)

12/14/22 UBS
UBS starts Bunge at Buy on near-term earnings power
12/13/22 UBS
Bunge initiated with a Buy at UBS
10/24/22 BofA
Green Plains price target lowered to $35 from $43 at BofA
10/24/22 BofA
Bunge price target lowered to $130 from $138 at BofA
BG Bunge
$98.92 /

-0.64 (-0.64%)

BG Bunge
$98.92 /

-0.64 (-0.64%)

BG Bunge
$98.92 /

-0.64 (-0.64%)

Recommendations
KKR price target raised to $80 from $72 at JMP Securities » 06:00
02/08/23
02/08
06:00
02/08/23
06:00
KKR

KKR

$58.93 /

+2.905 (+5.19%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KKR KKR
$58.93 /

+2.905 (+5.19%)

KKR KKR
$58.93 /

+2.905 (+5.19%)

01/31/23 BMO Capital
Franklin Resources price target raised to $23 from $22 at BMO Capital
01/19/23 BMO Capital
KKR should be bought on any KREST-induced weakness, says BMO Capital
01/11/23 Deutsche Bank
KKR price target raised to $67 from $66 at Deutsche Bank
01/10/23 JMP Securities
KKR price target lowered to $72 from $74 at JMP Securities
KKR KKR
$58.93 /

+2.905 (+5.19%)

KKR KKR
$58.93 /

+2.905 (+5.19%)

KKR KKR
$58.93 /

+2.905 (+5.19%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.